Zhu Bin, Zhou Guoping, Wang Shiwei, Wang Lan, Wang Wei
Department of Radiology, Zhejiang Medical and Health Group Quzhou Hospital (Zhejiang Quhua Hospital), Quzhou, China.
J Gastrointest Oncol. 2023 Feb 28;14(1):119-127. doi: 10.21037/jgo-23-30. Epub 2023 Feb 20.
The apparent diffusion coefficient is a parameter measured by magnetic resonance imaging (MRI). Studies in breast cancer and osteosarcoma have shown that the apparent diffusion coefficient has a good correlation with the efficacy of neoadjuvant chemotherapy. However, to date, no studies have evaluated the association between the apparent diffusion coefficient and the preoperative chemotherapy response of patients with locally advanced gastric cancer.
The data of 143 patients with locally advanced gastric cancer admitted to Zhejiang Medical and Health Group Quzhou Hospital (Zhejiang Quhua Hospital) from January 2018 to January 2019 were retrospectively collected. All the patients underwent preoperative chemotherapy and dynamic enhanced MRI to analyze the correlation between the apparent diffusion coefficient and preoperative chemotherapy response.
Compared to the control group, the apparent diffusion coefficient of the objective remission group was significantly increased [(1.16±0.26) ×10 . (0.95±0.26) ×10 mm/s, P<0.001]; the rate of the apparent diffusion coefficient >1.095×10 mm/s was significantly increased (61.29% . 30.00%, P<0.001). The apparent diffusion coefficient was valuable in predicting objective remission after preoperative chemotherapy in patients with locally advanced gastric cancer, the area under the curve (AUC) was 0.708 [95% confidence interval (CI): 0.621-0.796, P<0.001], the best diagnostic cut-off value was 1.095×10 mm/s, and the sensitivity and specificity were 0.613 and 0.700, respectively. The multivariate logistics regression analysis showed that the apparent diffusion coefficient of >1.095×10 mm/s was associated with the objective response of patients with locally advanced gastric cancer after preoperative chemotherapy [P=0.004, relative risk =3.135 (95% CI: 1.452-6.768)]. The apparent diffusion coefficient was valuable in predicting the non-recurrence of locally advanced gastric cancer patients, and the AUC was 0.647 (95% CI: 0.557-0.738, P=0.003). The apparent diffusion coefficient was also valuable in predicting the postoperative survival of patients with locally advanced gastric cancer, and the AUC was 0.630 (95% CI: 0.537-0.723, P=0.007).
The elevated apparent diffusion coefficient was associated with objective remission of the preoperative chemotherapy response and prognosis of patients with locally advanced gastric cancer.
表观扩散系数是通过磁共振成像(MRI)测量的一个参数。乳腺癌和骨肉瘤的研究表明,表观扩散系数与新辅助化疗的疗效具有良好的相关性。然而,迄今为止,尚无研究评估表观扩散系数与局部进展期胃癌患者术前化疗反应之间的关联。
回顾性收集2018年1月至2019年1月在浙江医疗健康集团衢州医院(浙江衢化医院)收治的143例局部进展期胃癌患者的数据。所有患者均接受术前化疗及动态增强MRI检查,分析表观扩散系数与术前化疗反应之间的相关性。
与对照组相比,客观缓解组的表观扩散系数显著升高[(1.16±0.26)×10⁻³.(0.95±0.26)×10⁻³mm²/s,P<0.001];表观扩散系数>1.095×10⁻³mm²/s的比例显著升高(61.29%.30.00%,P<0.001)。表观扩散系数对预测局部进展期胃癌患者术前化疗后的客观缓解有价值,曲线下面积(AUC)为0.708[95%置信区间(CI):0.621 - 0.796,P<0.001],最佳诊断临界值为1.095×10⁻³mm²/s,敏感性和特异性分别为0.613和0.700。多因素logistic回归分析显示,表观扩散系数>1.095×10⁻³mm²/s与局部进展期胃癌患者术前化疗后的客观反应相关[P = 0.004,相对危险度 = 3.135(95%CI:1.452 - 6.768)]。表观扩散系数对预测局部进展期胃癌患者无复发有价值,AUC为0.647(95%CI:0.557 - 0.738,P = 0.003)。表观扩散系数对预测局部进展期胃癌患者术后生存也有价值,AUC为0.630(95%CI:0.537 - 0.723,P = 0.007)。
表观扩散系数升高与局部进展期胃癌患者术前化疗反应的客观缓解及预后相关。